Medifast, Inc.
Price Action
Technical Summary
WEAKENINGMedifast, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 38), showing significant lag compared to the market leaders. Earnings contraction of 171% provides fundamental context to the price action. However, with RSI at 77, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $11.01 | +15.30% | ABOVE |
| 50 SMA | $10.52 | +20.61% | ABOVE |
| 100 SMA | $10.90 | +16.41% | ABOVE |
| 150 SMA | $11.30 | +12.30% | ABOVE |
| 200 SMA | $11.94 | +6.24% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MED in an uptrend right now?
MED has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is MED overbought or oversold?
MED's RSI (14) is 77. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is MED outperforming the market?
MED has a Relative Strength (RS) Rating of 38 out of 99. MED is currently lagging the broader market.
Where is MED in its 52-week range?
MED is trading at $12.69, which is 82% of its 52-week high ($15.46) and 56% above its 52-week low ($9.22).
How volatile is MED?
MED has a Beta of 0.94 and 52-week volatility of 38%. It's less volatile than the S&P 500 - generally more stable.